carnitine has been researched along with Carcinoma, Renal Cell in 3 studies
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the potential role of levocarnitine supplementation for cancer-related fatigue in patients treated with sunitinib." | 9.30 | Can levocarnitine supplementation improve fatigue caused by sunitinib as a treatment for renal cell carcinoma? A single-center prospective pilot study. ( Kobayashi, K; Masumori, N; Shindo, T; Tanaka, T, 2019) |
| "To evaluate the potential role of levocarnitine supplementation for cancer-related fatigue in patients treated with sunitinib." | 5.30 | Can levocarnitine supplementation improve fatigue caused by sunitinib as a treatment for renal cell carcinoma? A single-center prospective pilot study. ( Kobayashi, K; Masumori, N; Shindo, T; Tanaka, T, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, W | 1 |
| Wang, X | 1 |
| Zhang, X | 1 |
| Gong, P | 1 |
| Ding, D | 1 |
| Wang, N | 1 |
| Wang, Z | 1 |
| Shindo, T | 1 |
| Kobayashi, K | 1 |
| Tanaka, T | 1 |
| Masumori, N | 1 |
| Schöffski, P | 1 |
| Guillem, V | 1 |
| Garcia, M | 1 |
| Rivera, F | 1 |
| Tabernero, J | 1 |
| Cullell, M | 1 |
| Lopez-Martin, JA | 1 |
| Pollard, P | 1 |
| Dumez, H | 1 |
| del Muro, XG | 1 |
| Paz-Ares, L | 1 |
2 trials available for carnitine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Can levocarnitine supplementation improve fatigue caused by sunitinib as a treatment for renal cell carcinoma? A single-center prospective pilot study.
Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Carnitine; Dietary Supplements; Fatigue; Female; | 2019 |
Phase II randomized study of Plitidepsin (Aplidin), alone or in association with L-carnitine, in patients with unresectable advanced renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal | 2009 |
1 other study available for carnitine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics.
Topics: Adult; Biomarkers, Tumor; Carcinoma, Renal Cell; Carnitine; Cholesterol Esters; Chromatography, High | 2021 |